Resolving the Smoking Paradox: No Evidence for Smoking-Induced Preconditioning in Large Vessel Occlusion Stroke
European Neurology · 2023
DOI: 10.1159/000533436 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Neurology, 2023. Verfasst von Roni E Widmer und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, University Hospital Zurich, Zurich, Switzerland, RoniEsther.Widmer@usz.ch. Hauptthemen laut MEDLINE: Ischemic Stroke, Stroke, Arterial Occlusive Diseases, Brain Ischemia. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Schlaganfall
Abstract (Originalsprache)
Introduction
Smoking is an established risk factor for stroke. However, several studies have reported a better outcome after stroke for patients who smoke. According to this “smoking paradox” hypothesis, smoking might promote less severe strokes, higher collateral scores, and smaller infarct cores.
Methods
In this retrospective study, we screened data of 2,980 acute ischemic stroke patients with MCA-M1 occlusion treated with mechanical thrombectomy. Patients were categorized according to smoking status (current, former, or never). We assessed univariate associations between clinical characteristics and smoking status. Subsequently, we used adjusted regression analysis to evaluate associations of smoking with stroke severity on admission (National Institutes of Health Stroke Scale [NIHSS]; primary endpoint), infarct core volume, and collateral status (secondary endpoints).
Results
Out of 320 patients, 19.7% (n = 63) were current smokers and 18.8% (n = 60) were former smokers. Admission NIHSS, reperfusion success, and modified Rankin Scale (mRS) after 3–6 months were similar in all groups. Current smokers were younger, more often male and less likely to have atrial fibrillation compared to former and never smokers. In regression analyses, smoking status was neither associated with admission NIHSS (estimate 0.54, 95% confidence interval [CI]: −1.27–2.35, p = 0.557) nor with collateral status (estimate 0.79, 95% CI: 0.44–1.44, p = 0.447) or infarct core volume (estimate −0.69, 95% CI: −15.15–13.77, p = 0.925 for current vs. never smokers).
Conclusion
We could not confirm the smoking paradox. Our results support the fact that smoking causes stroke at a younger age, highlighting the role of smoking as a modifiable vascular risk factor.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology, University Hospital Zurich, Zurich, Switzerland, RoniEsther.Widmer@usz.ch.
- Clinical Neuroscience Center, University Hospital Zurich and University of Zurich, Zurich, Switzerland, RoniEsther.Widmer@usz.ch.
- Clinical Neuroscience Center, University Hospital Zurich and University of Zurich, Zurich, Switzerland.
- Department of Neuroradiology, University Hospital Zurich, Zurich, Switzerland.
- Department of Neurology, University Hospital Zurich, Zurich, Switzerland.
- Epidemiology, Biostatistics and Prevention Institute (EBPI), University of Zurich, Zurich, Switzerland.
Zitieren
APA
Widmer, R. E., Bink, A., Hamann, J., Herzog, L., El Amki, M., Sarikaya, H., Kulcsar, Z., Luft, A. R., & Wegener, S. (2023). Resolving the Smoking Paradox: No Evidence for Smoking-Induced Preconditioning in Large Vessel Occlusion Stroke. European Neurology. https://doi.org/10.1159/000533436
Vancouver
Widmer RE, Bink A, Hamann J, Herzog L, El Amki M, Sarikaya H, et al. Resolving the Smoking Paradox: No Evidence for Smoking-Induced Preconditioning in Large Vessel Occlusion Stroke. European Neurology. 2023. doi:10.1159/000533436
BibTeX
@article{Widmer2023,
author = {Widmer, Roni E and Bink, Andrea and Hamann, Janne and Herzog, Lisa and El Amki, Mohamad and Sarikaya, Hakan and Kulcsar, Zsolt and Luft, Andreas R and Wegener, Susanne},
title = {Resolving the Smoking Paradox: No Evidence for Smoking-Induced Preconditioning in Large Vessel Occlusion Stroke},
journal = {European Neurology},
year = {2023},
doi = {10.1159/000533436}
}
EUVIMED